A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk jfor both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy
A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident sand recurrent coronary artery disease events as well as san enhsanced clinical benefit from statin therapy
A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident nad recurrent coronary artery disease events as well as na enhnaced clinical benefit from statin therapy
A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease evets as well as an enhanced clinical benefit from statin therapy
A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident ad recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy
A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both iecidnnt and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy
A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A multi-locus genetic risk scor study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy
A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A mtlui-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy
A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A multi-locus ggenetic risk score study based on a combination of loci including the ABO ggene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy
A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent coronary artery disease events as well as an enhanced clinical benefit from statin therapy|A multi-locus genetic risk score study based on a combination of loci including the ABO gene identified individuals at increased risk for both incident and recurrent oronary artery disease events as well as an enhanced clinical benefit from statin therapy
